This was reported by TASS with reference to a representative of the Ministry of Health of the Federal Republic of Germany.

“In principle, the situation is such that only those approved here, in the EU, vaccines really have this approval and are recognized,” he said.

The Russian Sputnik V coronavirus vaccine is currently registered in different countries with a total population of more than three billion people.

The effectiveness of the drug is 97.6%.

Foreign partners continue to show interest in the Russian vaccine - according to the CEO of the Russian Direct Investment Fund (RDIF), Hungary, Vietnam and a number of other countries have made inquiries about the possibility of producing Sputnik V on their territory.